(Q57306207)

Jiri Lukas

10

0 references

Dario Greco

Dario Greco

3

0 references

Heli Nevanlinna

Heli Nevanlinna

14

0 references

Jiřina Bártková

2

Jirina Bartkova

0 references

Jiří Bártek

13

Jiri Bartek

0 references

Carl Blomqvist

12

Carl Blomqvist

0 references

Rainer Fagerholm

5

Rainer Fagerholm

0 references

Päivi Heikkilä

11

Päivi Heikkilä

0 references

Maral Jamshidi

1

Maral Jamshidi

0 references

Johanna Mattson

7

Johanna Mattson

0 references

Radek Vrtěl

9

Radek Vrtel

0 references

Kristiina Aittomäki

6

Kristiina Aittomäki

0 references

author name string

Kenneth Villman

Breast Cancer Research and Treatment

8

0 references

language of work or name

English

0 references

publication date

25 June 2011

0 references

published in

0 references

volume

132

0 references

issue

3

0 references

page(s)

955-968

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10549-011-1629-5

0 references

cites work

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

NQO1 stabilizes p53 through a distinct pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Crosstalk of reactive oxygen species and NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Good cop, bad cop: the different faces of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Nuclear factor-kappaB activation: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

lumi: a pipeline for processing Illumina microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Genomic databases and resources at the National Center for Biotechnology Information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Genome-wide analysis of estrogen receptor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1629-5